NHS to offer tablet which can reduce HIV risk by 90%

Dr Sheena McCormack (MRC Clinical Trials Unit at UCL) is leading a study into the use of Truvada, a daily tablet that offers up to a 90 per cent reduction in the risk of contracting HIV. Read: Independent, More: Times (£), Daily Mail